Zhitong Finance App News, Hanyu Pharmaceutical (300199.SZ) issued an announcement. The company recently received the “Notice of Acceptance” approved and issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”) regarding the clinical trial application for HY3003 tablets.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.